Fig. 7From: Evaluation of the clinical safety and performance of a narrow diameter (2.9 mm) bone-level implant: a 1-year prospective single-arm multicenter studySafety outcomes at month 12. The percentage of patients with adverse events (AEs) and adverse device effects (ADEs) are shown for patients with bone augmentation, patients without bone augmentation, and all patients. Number of patients in each group are shown on top of the bar graph. No SAEs, SADEs, USADEs, and DD were reportedBack to article page